Memory Lift Reviews & Complaints 2025: Is This Brain Supplement Worth Trying? (BUYER WARNING)
TALLMADGE, OH / ACCESS Newswire / September 13, 2025 / Memory Lift is a brain health supplement that is said...
News
Action Behavior Centers Partners with El Paso Chihuahuas for Autism Awareness Night
EL PASO, TX / ACCESS Newswire / September 13, 2025 / Action Behavior Centers (ABC), a leading provider of evidence-based...
Hapbee Strengthens Leadership Team with Key Appointments; Provides Update on Shares-for-Debt Settlement
New leadership roles designed to fast-track Hapbee’s product strategy and accelerate product deploymentsVANCOUVER, British Columbia, Sept. 12, 2025 (GLOBE NEWSWIRE)...
Aja Health And Wellness Inc. Provides Update on Delay in Filing Financial Statements
Not for dissemination in the United States of America VANCOUVER, British Columbia, Sept. 12, 2025 (GLOBE NEWSWIRE) -- Aja Health...
Avicanna Announces Change in CFO
TORONTO, Sept. 12, 2025 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a...
BioNxt Announces Shares for Debt Settlement
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, BC / ACCESS...
Onco-Innovations to Chair Colorectal Cancer Canada Precision Oncology Forum Driving the Future of Cancer Care
VANCOUVER, BC / ACCESS Newswire / September 12, 2025 / Onco-Innovations Limited (CBOE CA:ONCO)(Frankfurt:W1H)(WKN:A3EKSZ)(OTCQB:ONNVF) ("Onco" or the "Company")is pleased to...
Akanda Announces $12.0 Million Convertible Note Offering
Toronto, Ontario--(Newsfile Corp. - September 12, 2025) - Akanda Corp. (NASDAQ: AKAN) ("Akanda" or the "Company") today announced the execution and closing...
RXST Deadline: Rosen Law Firm Urges RxSight, Inc. (NASDAQ: RXST) Stockholders to Contact the Firm for Information About Their Rights
NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action...
Myriad Systems Launches Myriad Motion to Revolutionize EHR Onboarding
System empowers providers to launch a fully integrated practice management solution, enhancing efficiency and patient careWHITE PLAINS, N.Y.--(BUSINESS WIRE)--#AIinHealthcare--Myriad Systems,...
MIRA Pharmaceuticals Shareholders Approve Acquisition of SKNY Pharmaceuticals, Advancing Next-Generation Oral Therapeutic for Obesity and Smoking Cessation
SKNY transaction strengthens MIRA pipeline with SKNY-1, a differentiated oral candidate that has demonstrated up to 30% weight loss and...
Zomedica’s Fourth Friday at Four Webinar Returns: Spotlight on TRUVIEW(R) Digital Cytology Microscope – Transforming Veterinary Imaging
Cutting-Edge Digital Microscopy System Featured in Monthly Series Showcasing Innovation in Veterinary Care ANN ARBOR, MI / ACCESS Newswire /...
HealthLynked Strengthens Intellectual Property Portfolio with New Patent Filings in AI and Patient Record Management
NAPLES, Fla., Sept. 12, 2025 (GLOBE NEWSWIRE) -- via IBN -- HealthLynked Corp. (OTCQB: HLYK), a leader in patient-centric healthcare...
24/7 Market News: Kraig Labs Positioned at the Forefront of the Next-Gen Materials Revolution
Spider Silk: The Breakthrough Material Powering the Future of Wearable TechDENVER, Sept. 12, 2025 (GLOBE NEWSWIRE) -- 247marketnews.com, a pioneer...
Anosh Inc Foundation, Led by Anosh Ahmed, Aims to Deliver 100,000 Free Meals in Dubai and Pakistan
Building on its Ramadan campaign, the foundation expands food relief efforts to reach vulnerable communities year-round. Philanthropist Anosh Ahmed with...
ALX Oncology Appoints Board Member Barbara Klencke, M.D., as Interim Chief Medical Officer
Dr. Barbara Klencke is an accomplished clinical leader with a distinguished track record in oncology drug development who currently serves...
InflaRx Regains Compliance with Nasdaq Minimum Bid Price Requirement
JENA, Germany, Sept. 12, 2025 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting...
Prenetics Announces Second Quarter 2025 Financial Results with IM8 on Track to Achieve $100M Annual Recurring Revenue by Year’s End
1st Half revenue grew 452.1% to $32.3 million YoY IM8 achieved $5.9 million revenue in August 2025, representing a CAGR1...
FibroBiologics Leadership Authors Opinion Editorial Highlighting Fibroblast Cells’ Therapeutic Advantages Over Traditional Stem Cell Therapies
HOUSTON, Sept. 12, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 270+ patents issued...
Interim results for the six months ended June 30, 2025
September 12, 2025 Biodexa Pharmaceuticals PLC(“Biodexa” or the “Company”) Interim results for the six months ended June 30, 2025 Biodexa...